Do you ever consider treating the axilla in patients with multiple nodes with ITCs?
Does the axilla have to be addressed surgically or with RT, given that the AMAROS trial eligibility criteria were amended to address sentinel lymph nodes with only ITC to be node negative, along with the results of IBCSG 23-01? Does it change if the patient is triple negative?
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on
ITC is treated like node negative and we do not address either by surgery or radiation for these early stage breast cancer treated by mastectomy.
Join for free or sign in to see the full answer
Mednet Member
Radiation Oncology · AIM Specialty Health
Answered on
Agree with above. IHC is considered node negative by definition. No further axillary treatment is required.
Join for free or sign in to see the full answer